allergic reaction semaglutide JAAD Case Reports published a dedicated Virtual Special Issue focusing on the intersection of GLP-1 agonists and cutaneous disease. We highlight this Case Report of a 46-year-old woman presented with a 4-year Side Effects of Semaglutide

It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes

Among these conditions are reactive oxygen species (ROS), nitric oxide (NO), altered expression of growth factors, and calcium signaling

Methylmalonic acid (MMA) and homocysteine levels become elevated in B12 deficiency, but these tests are not routinely available in all NHS laboratories and can be confounded by renal impairment

A perhaps surprising appearance in the top five focus areas was Prader-Willi syndrome, which is the focus of 56 studies